The majority (52%) of our patients with LM had ER+ PR+, Her‐2‐negative neoplasms, 16% were Her‐2 positive, and 26% were triple‐negative, which is similar to the proportions reported by others.25, 26, 27, 28, 29, 30, 31. The gene discussed is ERBB2; the disease is neoplasm.